Exact Mass: 559.1083

Exact Mass Matches: 559.1083

Found 49 metabolites which its exact mass value is equals to given mass value 559.1083, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Adenosine diphosphate ribose

{[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(3,4,5-trihydroxyoxolan-2-yl)methoxy]phosphoryl}oxy)phosphinic acid

C15H23N5O14P2 (559.0717)


Adenosine diphosphate ribose is a molecule formed into poly(ADP-ribose) or PAR chains by the enzyme poly ADP ribose polymerase or PARP. PARP is found in every cell nucleus. Its main role is to detect and signal single-strand DNA breaks (SSB) to the enzymatic machinery involved in the SSB repair. PARP activation is an immediate cellular response to metabolic, chemical, or radiation-induced DNA SSB damage. Once PARP detects a SSB, it binds to the DNA, and, after a structural change, begins the synthesis of a poly (ADP-ribose) chain (PAR) as a signal for the other DNA-repairing enzymes such as DNA ligase III (LigIII), DNA polymerase beta, and scaffolding proteins such as X-ray cross-complementing gene 1 (XRCC1). After repairing, the PAR chains are degraded via PAR glycohydrolase (PARG). ADP-ribose binds to and activates the TRPM2 ion channel. Adenosine diphosphate ribose is an intermediate in NAD metabolism. The enzyme NAD(P)+ nucleosidase [EC:3.2.2.6] catalyzes the production of this metabolite from nicotinamide adenine dinucleotide phosphate. This reaction is irreversible and occurs in the cytosol. Adenosine diphosphate ribose is a molecule formed into chains by the enzyme poly ADP ribose polymerase. COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

ADP-D-ribose

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl] hydrogen phosphate

C15H23N5O14P2 (559.0717)


A nucleotide-sugar having ADP as the nucleotide fragment and D-ribofuranos-5-yl as the sugar component. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Phosphoribosyl-AMP

{[(2R,3S,4R,5R)-5-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-imino-6,9-dihydro-1H-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C15H23N5O14P2 (559.0717)


Phosphoribosyl-AMP belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Phosphoribosyl-AMP is a very strong basic compound (based on its pKa). Phosphoribosyl-AMP is a nucleic acid component and is an intermediate in histidine biosynthesis. It is converted from phosphoribosyl-ATP via the enzyme phosphoribosyl-ATP diphosphatase (EC 3.6.1.31). It is then converted to phosphoribosylformiminoAICAR-phosphate via the enzyme phosphoribosyl-AMP cyclohydrolase (EC 3.5.4.19). Phosphoribosyl-AMP is a nucleic acid component, a purine-related compound. It is an intermediate in histidine biosynthesis. It is converted from Phosphoribosyl-ATP via the enzyme phosphoribosyl-ATP diphosphatase (EC 3.6.1.31). It is then converted to phosphoribosylformiminoAICAR-phosphate via the enzyme phosphoribosyl-AMP cyclohydrolase (EC 3.5.4.19). [HMDB]

   

dTDP-D-desosamine

dTDP-D-desosamine; dTDP-3-dimethylamino-3,4,6-trideoxy-D-glucose; dTDP-alpha-D-desosamine; dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucose; dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucopyranose

C18H31N3O13P2 (559.1332)


   
   

dTDP-beta-L-evernosamine

dTDP-beta-L-evernosamine; dTDP-3-amino-2,3,6-trideoxy-3-C-methyl-4-O-methyl-beta-L-arabino-hexopyranose

C18H31N3O13P2 (559.1332)


   

dTDP-4-ethylamino-3-O-methyl-2,4-dideoxy-L-threo-pentopyranose

dTDP-4-ethylamino-3-O-methyl-2,4-dideoxy-L-threo-pentopyranose

C18H31N3O13P2 (559.1332)


   
   
   

Gadoteridol

3-methyl-16,19,24-trioxo-2,17,18,25-tetraoxa-5lambda5,8lambda5,11lambda5,14lambda5-tetraaza-1-gadolinaoctacyclo[9.6.3.3^{1,8}.2^{5,14}.0^{1,5}.0^{1,8}.0^{1,11}.0^{1,14}]pentacosan-2-ium-5,8,11,14-tetrakis(ylium)-1,1-diuide

C17H29GdN4O7 (559.1277)


Gadoteridol provides contrast enhancement of the brain, spine and surrounding tissues resulting in improved visualization (compared with unenhanced MRI) of lesions with abnormal vascularity or those thought to cause a disruption of the normal blood brain barrier. Gadoteridol can also be used for whole body contrast enhanced MRI including the head, neck, liver, breast, musculoskeletal system and soft tissue pathologies. n MRI, visualization of normal and pathological brain tissue depends in part on variations in the radiofrequency signal intensity that occur with changes in proton density, alteration of the T1, and variation in T2. When placed in a magnetic field, gadoteridol shortens the T1 relaxation time in tissues where it accumulates. Abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadoteridol in lesions such as neoplasms, abscesses, and subacute infarcts. V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

   

ADP Ribose

{[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2,3,4-trihydroxy-5-oxopentyl)oxy]phosphoryl}oxy)phosphinic acid

C15H23N5O14P2 (559.0717)


Adp-ribose is a member of the class of compounds known as purine ribonucleoside diphosphates. Purine ribonucleoside diphosphates are purine ribobucleotides with diphosphate group linked to the ribose moiety. Adp-ribose is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Adp-ribose can be found in a number of food items such as common bean, horned melon, sapodilla, and red raspberry, which makes adp-ribose a potential biomarker for the consumption of these food products.

   

Acetic acid, 2-(4-((5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazol-1-yl)sulfonyl)phenoxy)-

Acetic acid, 2-(4-((5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazol-1-yl)sulfonyl)phenoxy)-

C25H25N3O8S2 (559.1083)


   

Adenosine diphosphate-D-ribose

{[(2R,3S,4R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[hydroxy({[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methoxy})phosphoryl]oxy})phosphinic acid

C15H23N5O14P2 (559.0717)


Adenosine diphosphate-d-ribose is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adenosine diphosphate-d-ribose can be found in mung bean, which makes adenosine diphosphate-d-ribose a potential biomarker for the consumption of this food product.

   

Adenosine diphosphate ribose

Adenosine diphosphate ribose

C15H23N5O14P2 (559.0717)


   

Tetra-Ac-Antibiotic A 33853

Tetra-Ac-Antibiotic A 33853

C28H21N3O10 (559.1227)


   

convolutamide A|N-Tetradecanoyl-Deacylconvolutamide

convolutamide A|N-Tetradecanoyl-Deacylconvolutamide

C24H35Br2NO4 (559.0933)


   
   

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl[hydroxy-[(2R,3R,4R)-2,3,4-trihydroxy-5-oxopentoxy]phosphoryl] hydrogenphosphate

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl[hydroxy-[(2R,3R,4R)-2,3,4-trihydroxy-5-oxopentoxy]phosphoryl] hydrogenphosphate

C15H23N5O14P2 (559.0717)


   

Phosphoribosyl-AMP

N1-(5-Phospho-D-ribosyl)-AMP

C15H23N5O14P2 (559.0717)


   

ADENOSINE 5'-DIPHOSPHORIBOSE

ADENOSINE 5'-DIPHOSPHORIBOSE

C15H23N5O14P2 (559.0717)


   

Adenosine 5-diphosphoribose

Adenosine 5-diphosphoribose

C15H23N5O14P2 (559.0717)


   

Gadoteridol

gadolinium(3+) ion 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate

C17H29GdN4O7 (559.1277)


V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

   

Bis[1-(2-pyridylazo)-2-naphtholato]copper(II)

Bis[1-(2-pyridylazo)-2-naphtholato]copper(II)

C30H20CuN6O2 (559.0944)


   

aluminum phthalocyanine hydroxide

aluminum phthalocyanine hydroxide

C32H20AlN8O (559.1575)


   

GADOTERIC ACID

[2,2,2,2-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(3-)]gadolinium

C16H25GdN4O8 (559.0913)


V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media D064449 - Sequestering Agents > D002614 - Chelating Agents

   

2-(dimethylamino)-2-biphenylyl-palladium(ii) chloride dinorbornylphosphine complex

2-(dimethylamino)-2-biphenylyl-palladium(ii) chloride dinorbornylphosphine complex

C28H37ClNPPd (559.1387)


   

4-Methylumbelliferyl 3,4,6-tri-O-acetyl-2-deoxy-2-trifluoroacetamido-b-D-glucopyranoside

4-Methylumbelliferyl 3,4,6-tri-O-acetyl-2-deoxy-2-trifluoroacetamido-b-D-glucopyranoside

C24H24F3NO11 (559.1301)


   

Galicaftor

Galicaftor

C28H21F4NO7 (559.1254)


C87006 - Pharmacological Chaperone

   

[(2r,3s,4r,5r)-5-(6-Aminopurin-9-Yl)-3,4-Dihydroxy-Oxolan-2-Yl]methyl [hydroxy-[[(2r,3s,4r,5s)-3,4,5-Trihydroxyoxolan-2-Yl]methoxy]phosphoryl] Hydrogen Phosphate

[(2r,3s,4r,5r)-5-(6-Aminopurin-9-Yl)-3,4-Dihydroxy-Oxolan-2-Yl]methyl [hydroxy-[[(2r,3s,4r,5s)-3,4,5-Trihydroxyoxolan-2-Yl]methoxy]phosphoryl] Hydrogen Phosphate

C15H23N5O14P2 (559.0717)


COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

dTDP-alpha-D-desosamine

dTDP-alpha-D-desosamine

C18H31N3O13P2 (559.1332)


   

N(10)-Bromoacetyl-5,8-dideazafolic acid

N(10)-Bromoacetyl-5,8-dideazafolic acid

C23H22BrN5O7 (559.0703)


   

2-(5-Phosphoribosyl)-5-adenosine monophosphate

2-(5-Phosphoribosyl)-5-adenosine monophosphate

C15H23N5O14P2 (559.0717)


   

[6-(Diethylamino)-9-(2,4-disulfophenyl)xanthen-3-ylidene]-diethylazanium

[6-(Diethylamino)-9-(2,4-disulfophenyl)xanthen-3-ylidene]-diethylazanium

C27H31N2O7S2+ (559.1573)


   

Adenosine diphosphate-D-ribose

Adenosine diphosphate-D-ribose

C15H23N5O14P2 (559.0717)


   

Gadolinium-HP-Do 3A

Gadolinium-HP-Do 3A

C17H29GdN4O7 (559.1277)


V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

   

2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(2,2,2-trifluoroethylsulfonylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-fluorophenyl)acetamide

2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(2,2,2-trifluoroethylsulfonylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-fluorophenyl)acetamide

C24H25F4N3O6S (559.14)


   
   

Apalcillin potassium

Apalcillin potassium

C25H22KN5O6S (559.0928)


   

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(6,7-dimethoxy-2H-1,3-benzodioxol-5-yl)-2-hydroxy-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(6,7-dimethoxy-2H-1,3-benzodioxol-5-yl)-2-hydroxy-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C22H29N3O12S (559.1472)


   

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl phosphate

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl phosphate

C15H23N5O14P2 (559.0717)


   

ADP-Ribose

ADP-Ribose

C15H23N5O14P2 (559.0717)


COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

ADP-alpha-D-ribose

ADP-alpha-D-ribose

C15H23N5O14P2 (559.0717)


An ADP-D-ribose with beta configuration at the anomeric centre.

   

1-(5-phospho-beta-D-ribosyl)-5-AMP

1-(5-phospho-beta-D-ribosyl)-5-AMP

C15H23N5O14P2 (559.0717)


An AMP-sugar in which the hydrogen at position 1 of AMP is substituted by a 5-phospho-beta-D-ribosyl group.

   

ADP-beta-D-ribose

ADP-beta-D-ribose

C15H23N5O14P2 (559.0717)


An ADP-D-ribose with alpha configuration at the anomeric centre.

   

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-tetradecanoylpyrrolidin-2-one

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-tetradecanoylpyrrolidin-2-one

C24H35Br2NO4 (559.0933)


   

12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28-dithia-3,16,18-triazaoctacyclo[12.12.2.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]octacosa-6(10),19,21,23-tetraene-2,11,15-trione

12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28-dithia-3,16,18-triazaoctacyclo[12.12.2.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]octacosa-6(10),19,21,23-tetraene-2,11,15-trione

C25H25N3O8S2 (559.1083)


   

(1s,8r,13s,14s,17s,26s)-12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28-dithia-3,16,18-triazaoctacyclo[12.12.2.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]octacosa-6(10),19,21,23-tetraene-2,11,15-trione

(1s,8r,13s,14s,17s,26s)-12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28-dithia-3,16,18-triazaoctacyclo[12.12.2.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]octacosa-6(10),19,21,23-tetraene-2,11,15-trione

C25H25N3O8S2 (559.1083)


   

3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-tetradecanoylpyrrolidin-2-one

3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-tetradecanoylpyrrolidin-2-one

C24H35Br2NO4 (559.0933)


   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2r,3s,4s,5r,6s)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}oxan-2-yl]methyl 3-hydroxy-7-methoxy-2-methylidene-1,4-benzoxazine-5-carboxylate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2r,3s,4s,5r,6s)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}oxan-2-yl]methyl 3-hydroxy-7-methoxy-2-methylidene-1,4-benzoxazine-5-carboxylate

C23H29NO15 (559.1537)